Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 01/07/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 229 publications
Optimizing COPD management in Latin America: a cost-effectiveness analysis of FF/UMEC/VI in Colombia.
Journal: Expert review of pharmacoeconomics & outcomes research
Published: December 11, 2025
Long-acting β2 agonist (LABA) with a long-acting muscarinic receptor antagonist (LAMA) promotes human airway smooth muscle (HASM) relaxation and circumvents β2 adrenergic receptor tachyphylaxis.
Journal: Respiratory research
Published: September 23, 2025
Impact of umeclidinium/vilanterol dual bronchodilator therapy on pulmonary function and inflammatory responses in stable COPD patients.
Journal: Scientific reports
Published: June 11, 2025
A Brief Report on a Systematic Review of Real-World Effectiveness Studies of ICS/LAMA/LABA for Treatment of Adults with Asthma in the US.
Journal: Pulmonary therapy
Published: December 18, 2024
Real-life effectiveness of once-daily single-inhaler triple therapy (FF-UMEC-VI) after switching from dual therapy (ICS-LABA) in patients with symptomatic asthma: trelegy ellipta for real asthma control study.
Journal: Frontiers in allergy
Published: December 01, 2024
Comparison chart: Some inhaled drugs for treatment of asthma.
Journal: The Medical letter on drugs and therapeutics
Published: November 19, 2024
Cost-Effectiveness of Single-Inhaler Versus Multiple-Inhaler Triple Therapy in COPD: A German Healthcare Perspective.
Journal: International journal of chronic obstructive pulmonary disease
Published: October 10, 2024
A cost-effectiveness analysis comparing single-inhaler extrafine beclomethasone/formoterol/glycopyrronium bromide against other SITTs in adult patients with uncontrolled asthma in England.
Journal: Health economics review
Published: September 10, 2024
In Vitro Analysis of Aerodynamic Properties and Co-Deposition of a Fixed-Dose Combination of Fluticasone Furoate, Umeclidinium Bromide, and Vilanterol Trifenatate.
Journal: Pharmaceutics
Published: September 01, 2024
Last Updated: 01/07/2026